Until now, much of the AI narrative has been centered on diagnostic excellence—AI detecting cancer on medical scans, identifying rare genetic disorders, or flagging abnormalities in patient charts ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Regenxbio is ranked Strong Buy due to low EV, strong partnerships, royalty income, bullish trends, and buyout potential.

I’m captivated by my new personal health tracker ... of sleep medication, which is just scary.” One woman Baron treated talked her general practitioner into prescribing large doses of an ...

Whether it’s magnesium, collagen or miracle ‘green powders’, we are being bombarded with must-take supplements all the time.

After hearing from African leaders and getting their buy-in, public health leaders agreed on a three-part plan to address the ...

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...

How continent is navigating decades-old obstacles to build robust vaccine industry ANALYSIS | The African Union has embarked ...

Maintaining strong relationships and credibility with the FDA and industry partners remains a top priority as we chart our future course. The Company continues to be on track financially and we ...

Hold the syringe upright (with the needle on top) and pull the plunger down until the tip reaches a measurement equal to the dose you plan ... doctor for a chart to keep track of your injection ...